pdf-articles Ratings /ratings/en/research/pdf-articles/201203-credit-conditions-emerging-markets-a-vaccine-won-t-erase-all-risks-100047824 content esgSubNav

Credit Conditions Emerging Markets: A Vaccine Won't Erase All Risks

December 3, 2020

Credit conditions in emerging markets (EMs) continue to improve following positive news about progress in developing a coronavirus vaccine, which augurs well for a faster recovery over the second half of 2021.


Register with S&P Global Ratings

Register now to access exclusive content, events, tools, and more.

Go Back